Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 75701-75750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05798923
A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension
PHASE2Active, not recruiting
10 participants
Started: Apr 3, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor4 locations
NCT02915198
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
PHASE4Recruiting
7,410 participants
Started: Apr 3, 2023 · Completed: Mar 31, 2029
3 conditions1 sponsor40 locations
NCT05521984
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
PHASE1Recruiting
20 participants
Started: Apr 3, 2023 · Completed: Nov 30, 2026
2 conditions2 sponsors1 location
NCT05698589
COMpassion for Psychiatric Disorders And Self-Stigma
NARecruiting
336 participants
Started: Apr 3, 2023 · Completed: Mar 1, 2028
5 conditions1 sponsor7 locations
NCT05773482
Effects of Breathing and Attention Training (BAT) on Pain Modulation
NARecruiting
40 participants
Started: Apr 3, 2023 · Completed: Mar 9, 2028
1 condition1 sponsor1 location
NCT05766020
Training Listening Skills With the Inclusion of Cognitive Control
NAActive, not recruiting
60 participants
Started: Apr 3, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05979077
Children's Hospital Academic Medical Organization (CHAMO) MyChart Study
NAActive, not recruiting
200 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05772494
Assessment of Activity Limitations, a Basis for Understanding the Need for Sickness Certificate and Rehabilitation
NAActive, not recruiting
150 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05641948
Radiofrequency Denervation and Brain Imaging
N/ARecruiting
40 participants
Started: Apr 3, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06050278
Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens
N/ARecruiting
10 participants
Started: Apr 3, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05790889
A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.
PHASE1/PHASE2Recruiting
480 participants
Started: Apr 3, 2023 · Completed: May 30, 2026
1 condition4 sponsors1 location
NCT05447689
Mind-Body Skills Group for Graduate Students
NARecruiting
60 participants
Started: Apr 3, 2023 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT05802797
Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules
EARLY_PHASE1Active, not recruiting
24 participants
Started: Apr 3, 2023 · Completed: Jul 10, 2026
1 condition1 sponsor1 location
NCT06066294
A Comparison of Safety and Immunogenicity of Rabies Pre Exposure Prophylaxis Regimen Between Gvt of India Approved and WHO Approved.
PHASE3Recruiting
115 participants
Started: Apr 3, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT04875936
Neurofeedback Intervention for Reading Deficits in Subacute Stroke
NARecruiting
28 participants
Started: Apr 3, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05951673
Adolescent Girls Initiative for Learning and Empowerment: Impact Evaluation of a Safe Space-Based Life Skills Training and Digital Literacy Training in Nigeria Space-Based Life Skills Training and Digital Literacy Training in Nigeria
NARecruiting
8,463 participants
Started: Apr 3, 2023 · Completed: Aug 31, 2026
5 conditions1 sponsor1 location
NCT05780632
A Prospective Observational Study of Biomarkers for a Personalised IVF Treatment
N/ARecruiting
500 participants
Started: Apr 3, 2023 · Completed: Mar 31, 2025
1 condition7 sponsors1 location
NCT05453461
ADVANCED FSHD-COM: New Clinical Outcome Measures to Evaluate Non-ambulant FSHD Patients, a Pilot Study
NAActive, not recruiting
30 participants
Started: Apr 3, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT05576090
UCLA REST Study (REsearch on Sleep Techniques)
NARecruiting
240 participants
Started: Apr 3, 2023 · Completed: May 30, 2027
3 conditions1 sponsor1 location
NCT06275945
Feasibility Study of A VoRo UrologIc ScaffolD (ARID)
PHASE2Active, not recruiting
40 participants
Started: Apr 3, 2023 · Completed: Oct 30, 2026
2 conditions2 sponsors1 location
NCT05811754
Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions
N/ANot yet recruiting
2,844 participants
Started: Apr 3, 2023 · Completed: Apr 30, 2029
1 condition2 sponsors0 locations
NCT05557292
RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
PHASE1Recruiting
48 participants
Started: Apr 3, 2023 · Completed: Apr 30, 2030
2 conditions3 sponsors1 location
NCT05375643
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
NARecruiting
210 participants
Started: Apr 3, 2023 · Completed: Jul 30, 2028
3 conditions2 sponsors3 locations
NCT05437159
Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech
NARecruiting
2 participants
Started: Apr 3, 2023 · Completed: May 31, 2026
2 conditions4 sponsors3 locations
NCT05731791
Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation
NAActive, not recruiting
17 participants
Started: Apr 3, 2023 · Completed: Jul 1, 2029
1 condition1 sponsor1 location
NCT05238103
Impact of a Corrie Cardiac Rehabilitation Program
NAActive, not recruiting
259 participants
Started: Apr 3, 2023 · Completed: Oct 13, 2025
7 conditions3 sponsors1 location
NCT05786066
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
PHASE2Recruiting
30 participants
Started: Apr 3, 2023 · Completed: Mar 31, 2033
5 conditions4 sponsors1 location
NCT07100743
Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE)
NAActive, not recruiting
78 participants
Started: Apr 3, 2023 · Completed: Mar 2, 2026
1 condition2 sponsors1 location
NCT06731283
Evaluation of Serological Markers of Vitiligo Activity
N/AActive, not recruiting
85 participants
Started: Apr 3, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT04358315
Consumer Assessment of Tobacco Flavor and Odor
N/AActive, not recruiting
29 participants
Started: Apr 3, 2023 · Completed: Dec 9, 2025
2 conditions3 sponsors1 location
NCT05813405
Correlation Between Coronary Artery and Brain Study
N/ANot yet recruiting
1,000 participants
Started: Apr 3, 2023 · Completed: Jan 1, 2028
1 condition1 sponsor0 locations
NCT05794906
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies
PHASE3Recruiting
970 participants
Started: Apr 3, 2023 · Completed: Mar 29, 2030
1 condition1 sponsor300 locations
NCT05769777
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
PHASE2Recruiting
901 participants
Started: Apr 3, 2023 · Completed: Jun 11, 2031
1 condition1 sponsor183 locations
NCT05657990
Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
EARLY_PHASE1Recruiting
46 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT05596175
Super-Rehab: a Novel Approach to Treat Atrial Fibrillation
NAActive, not recruiting
36 participants
Started: Apr 3, 2023 · Completed: Nov 30, 2025
2 conditions5 sponsors1 location
NCT05613426
Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI
PHASE4Recruiting
330 participants
Started: Apr 3, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor6 locations
NCT05631899
CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors
PHASE1Recruiting
15 participants
Started: Apr 3, 2023 · Completed: Dec 30, 2026
5 conditions2 sponsors1 location
NCT05695521
Regulatory T Cells for Amyotrophic Lateral Sclerosis
PHASE1Active, not recruiting
66 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT05728775
REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry
PHASE4Recruiting
7,188 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor44 locations
NCT05803421
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
PHASE3Active, not recruiting
2,749 participants
Started: Apr 3, 2023 · Completed: Mar 31, 2026
6 conditions1 sponsor358 locations
NCT05723562
A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer
PHASE2Active, not recruiting
154 participants
Started: Apr 3, 2023 · Completed: Oct 11, 2029
1 condition1 sponsor42 locations
NCT05856981
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
PHASE1Recruiting
90 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor9 locations
NCT05798351
Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae on Admission to a French University Teaching Hospital
N/ARecruiting
1,195 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05772195
Central London Patient Safety Research Collaboration
N/AActive, not recruiting
500,000 participants
Started: Apr 3, 2023 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT06586242
Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy
PHASE2Recruiting
194 participants
Started: Apr 3, 2023 · Completed: Apr 30, 2036
1 condition1 sponsor1 location
NCT05784558
RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up
N/ANot yet recruiting
2,500 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor0 locations
NCT06937255
Dynamic Assessment of the Risk for Language and Reading Disorders in Monolingual and Multilingual Children
NARecruiting
150 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05748860
PRecision Ecmo in CardIogenic Shock Evaluation
N/ANot yet recruiting
236 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT05704985
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
PHASE1Active, not recruiting
39 participants
Started: Apr 3, 2023 · Completed: Oct 31, 2025
9 conditions1 sponsor7 locations
NCT05884632
Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients
NARecruiting
184 participants
Started: Apr 3, 2023 · Completed: Apr 30, 2030
1 condition1 sponsor1 location